Sorrento gets Brazilian ANVISA clearance to start Long COVID therapy trial
Sorrento Therapeutics has secured the Brazilian ANVISA authorisation to start a Phase IIa trial of COVI-MSC for treating long COVID.
Stay updated with breaking news from Processing Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sorrento Therapeutics has secured the Brazilian ANVISA authorisation to start a Phase IIa trial of COVI-MSC for treating long COVID.
I-Mab has dosed the first subject in Phase II trial of efineptakin alfa plus pembrolizumab in advanced solid tumour patients in China.
2-D Materials Market Size | 2022 Present Scenario on Growth Analysis and High Demand to 2030
2-D Materials Market Size | 2022 Present Scenario on Growth Analysis and High Demand to 2030
Global Food Processing And Handling Equipment Market To Be Driven By The Rising Demand For Processed Foods And Innovation In Processing Technology In The F